# EDGAR Filing Document

**Accession Number:** 0001716166
**File Stem:** 0002074003-25-000001
**Filing Date:** 2025-6
**Character Count:** 6235
**Document Hash:** 223a4803521ca50a922b2486aaf5a6b0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002074003-25-000001.hdr.sgml**: 20250620

**ACCESSION NUMBER**: 0002074003-25-000001

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250609

**FILED AS OF DATE**: 20250620

**DATE AS OF CHANGE**: 20250620

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Skaff Michael C
- **CENTRAL INDEX KEY:** 0002074003

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39796
- **FILM NUMBER:** 251062526

**MAIL ADDRESS:**
- **STREET 1:** TWO TOWNE SQUARE
- **STREET 2:** STE. 810
- **CITY:** SOUTHFIELD
- **STATE:** MI
- **ZIP:** 48076
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Vivos Therapeutics, Inc.
- **CENTRAL INDEX KEY:** 0001716166
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 813224056
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 7921 SOUTHPARK PLAZA,
- **STREET 2:** SUITE 210
- **CITY:** LITTLETON
- **STATE:** CO
- **ZIP:** 80120
- **BUSINESS PHONE:** (866)908-4867

**MAIL ADDRESS:**
- **STREET 1:** 7921 SOUTHPARK PLAZA,
- **STREET 2:** SUITE 210
- **CITY:** LITTLETON
- **STATE:** CO
- **ZIP:** 80120

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Vivos BioTechnologies, Inc.
- **DATE OF NAME CHANGE:** 20170901

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Skaff Michael C<br><sub>(Last) (First) (Middle)</sub><br>TWO TOWNE SQUARE<br>STE. 810<br><sub>(Street)</sub><br>SOUTHFIELD, MI 48076<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Vivos Therapeutics, Inc. [ VVOS ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2025-06-09 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [X] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 514498 | I | By V-CO Investors LLC<sup>(1)</sup> |
| Common Stock | 828000 | I | By V-Co Investors 2 LLC<sup>(2)</sup> |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Pre-Funded Warrant | 2024-06-10 | 2034-06-10<sup>(3)</sup> | Common Stock | 2705768 | $0.0001 | I | By V-CO Investors LLC<sup>(1)</sup> |
| Common Stock Purchase Warrant | 2024-06-10 | 2029-06-10 | Common Stock | 3220266 | $2.204 | I | By V-CO Investors LLC<sup>(1)</sup> |
| Pre-Funded Warrant | 2025-06-09 | 2035-06-09<sup>(3)</sup> | Common Stock | 725258 | $0.0001 | I | By V-Co Investors 2 LLC<sup>(2)</sup> |
| Common Stock Purchase Warrant | 2025-06-09 | 2030-06-09 | Common Stock | 2329886 | $2.23 | I | By V-Co Investors 2 LLC<sup>(2)</sup> |

---

### Footnotes:

(1) The Reporting Person serves as Managing Director of SP Manager LLC, the Manager of V-CO Investors LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

(2) The Reporting Person serves as Managing Director of SP Manager LLC, the Manager of V-Co Investors 2 LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

(3) The Pre-Funded Warrant has a term ending on the complete exercise of the Pre-Funded Warrant.

**Signature:** Michael C. Skaff, as Managing Director SP Manager LLC, Manager of V-CO Investors LLC  
**Date:** 2025-06-20

**Signature:** Michael C. Skaff, as Managing Director SP Manager LLC, Manager of V-Co Investors 2 LLC  
**Date:** 2025-06-20

**Signature:** Michael C. Skaff, as Managing Director SP Manager LLC  
**Date:** 2025-06-20

**Signature:** Michael C. Skaff, Individual  
**Date:** 2025-06-20

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**